CESTEX DIN 01913026
Status: Marketed
Holder: ZOETIS CANADA INC
Health Canada record
| Active ingredient(s) | EPSIPRANTEL 25 MG |
|---|
| Dosage form | Tablet |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 31-Dec-1992 |
|---|
| Current status date | 08-Feb-2016 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing EPSIPRANTEL
| DIN | Product | Company | Form | Strength | Status |
|---|
| 01913034 | CESTEX | ZOETIS CANADA INC | Tablet | EPSIPRANTEL 12.5 MG | Marketed |
| 01912992 | CESTEX 100MG TABLETS | PFIZER CANADA INC ANIMAL HEALTH GROUP | Tablet | EPSIPRANTEL 100 MG | Cancelled Post Market |
| 01913018 | CESTEX 50MG TABLETS | PFIZER CANADA INC ANIMAL HEALTH GROUP | Tablet | EPSIPRANTEL 50 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 15284 | 2014-02-14 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBER (DIN) HOLDER |
| 5845 | 1998-06-18 | New Drug Submission (NDS) | |
Request a quote for CESTEX
How to read a Canadian DIN record